The Menopause Moment: A Review for Pharmacists

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists, Pharmacy Technicians

Description

Perimenopause and menopause are natural life stages that bring significant hormonal and physical changes for our patients. These transitions are often accompanied by distressing symptoms such as vasomotor instability, mood changes, sleep disturbances, and genitourinary concerns which can significantly impact quality of life. Despite their prevalence, these conditions are frequently under-recognized and inadequately managed.

Pharmacists play a vital role in supporting patients through the transitions of perimenopause, menopause, and post-menopause. This continuing education program provides a comprehensive overview of hormonal changes, symptom presentation, and treatment options. Participants will explore both pharmacological and non-pharmacological management strategies, lifestyle interventions, and safe supplement use. Designed to enhance clinical confidence and patient counseling skills, this program empowers pharmacists to deliver evidence-based, individualized care throughout the menopausal transition.

Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.


Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE #0046-9999-26-057-L99-P(Pharmacist) provides 2.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**

Objectives

• Describe the pathophysiology and clinical characteristics of perimenopause and menopause.
• Identify the signs and symptoms associated with perimenopause and menopause.
• Evaluate the risks and benefits of hormone therapy (HT) and non-hormonal treatments in managing perimenopausal and menopausal symptoms.
• Differentiate between topical and systemic forms of HT.
• Recommend nonpharmacologic therapy for menopausal symptoms.
• Determine the desired therapeutic outcomes for a patient taking HT.
• Educate patients on the treatment options, benefits, risks, and monitoring of HT.

Sessions